Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells-Reference-Cited by-同舟云学术

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Published:2023-07-20 Issue:1 Volume:14 Page:738-746
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Filon Mikolaj¹,Yang Bing¹,Purohit Tanaya A.¹,Schehr Jennifer²,Singh Anupama²,Bigarella Marcelo¹,Lewis Peter³,Denu John³,Lang Joshua²⁴,Jarrard David F.¹⁴

Affiliation:

1. Department of Urology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA

2. Department of Hematology/Oncology, University of Wisconsin, Madison, WI 53705, USA

3. Biomolecular Chemistry, University of Wisconsin, Madison, WI 53705, USA

4. Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, WI 53705, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Jemal;CA Cancer J Clin,2018

2. Identifying Dysregulated Epigenetic Enzyme Activity in Castrate-Resistant Prostate Cancer Development;Denu;ACS Chem Biol,2017

3. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes;Zhao;Cell,2009

4. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator;Cole;Nature,2008

5. The transcriptional coactivators p300 and CBP are histone acetyltransferases;Nakatani;Cell,1996

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation of androgen dependent and independent prostate cancer;Advances in Cancer Research;2024